|
COPYRIGHT 2005 International Medical News Group
GLASGOW, SCOTLAND -- A quarter century ago, a cohort of 30 patients with disorders of keratinization became pioneers at Cardiff University in Wales, being one of the first groups in the world to receive the oral retinoid etretinate for these difficult-to-treat inherited skin conditions, Ruwani Katugampola, B.M., said at the annual meeting of the British Association of Dermatologists.
"I would like to take you back 25 years to the day, to the Thursday morning oral session at the annual meeting...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
